Reich K, Baraliakos X, Coates LC, Elewski B, et al. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis. Br J Dermatol 2022 Mar 8. doi: 10.1111/bjd.21233.
PMID: 35257363